Wabco Holdings (WBC) Debuts New OnGuardMAX Advanced Emergency Braking System
- Futures fall on Trump's protectionist address
- Qualcomm (QCOM) Calls Apple's (AAPL) Claims 'Baseless'
- Unease over Trump sends dollar to one-and-half month low
- Kate Spade (KATE) Said to Attract Interest from Coach (COH) and Michael Kors (KORS) - Bloomberg
- European stocks fall, investors seek safety after Trump address
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
WABCO Holdings Inc. (NYSE: WBC) introduced its OnGuardMAX™ advanced emergency braking system (AEBS) for trucks and buses, which provides up to full braking when confronted with both stationary and moving vehicles ahead. WABCO is the industry’s first OEM independent system supplier to offer AEBS and OnGuardMAX marks another advanced technology that further enables automated driving for commercial vehicles.
Equipped with state-of-the-art 77GHz radar and a high-resolution camera, WABCO’s OnGuardMAX detects impending rear-end collisions with vehicles ahead and alerts the driver with distinct acoustic, visual and haptic warnings. Unless the driver takes appropriate corrective action, OnGuardMAX performs up to full braking when approaching both stationary and moving vehicles to bring the host vehicle to a complete stop, for example, when nearing a traffic jam.
Performing with high precision, even in low visibility conditions, OnGuardMAX meets regulatory standards globally for AEBS. In addition, the OnGuardMAX system provides lane-departure warning (LDW) functionality, which complies with government LDW mandates now in effect or expected in numerous countries around the world. OnGuardMAX’s system will also have capability for full braking from highway speed.
OnGuardMAX also brings commercial vehicles closer to automated highway driving. For example, its Adaptive Cruise Control (ACC) functionality will come with integrated Stop’n’Go functionality, which is intended to free up the driver from frequent acceleration and deceleration during traffic jams while maintaining a pre-set speed and a safe distance to the vehicle ahead. The system will also intelligently maintain speed control based on traffic flow.
“Our OnGuardMAX technology reflects WABCO’s ability to mobilize vehicle intelligence for original equipment manufacturers and fleets on our industry’s path toward autonomous driving,” said Jorge Solis, WABCO President, Truck, Bus and Car Original Equipment Manufacturers Division. “OnGuardMAX also significantly expands WABCO’s portfolio of advanced vehicle safety solutions engineered from our original OnGuard collision mitigation system.”
WABCO’s OnGuard™ collision mitigation system (CMS) was launched in 2007 in North America, the first CMS with active braking in that region. Industry-leading OnGuard systems have contributed strongly to enhancing vehicle safety with more than 45 billion highway miles clocked in the field on over 200 fleets, reporting a reduction of up to 87% in rear-end collisions.
In addition, WABCO’s OnGuardACTIVE™ system reacts to both moving and decelerating vehicles ahead. It can autonomously apply the brakes and bring the vehicle to a complete stop, helping to avoid or mitigate rear-end collisions.
WABCO is further differentiated as the commercial vehicle industry’s leading global supplier of solutions for collision mitigation and advanced emergency braking systems. Today, more than 250,000 OnGuard branded systems are on the road globally, resulting in vehicle and road safety improvements that help to avoid fatalities, injuries and accident-related costs. WABCO’s portfolio of OnGuard safety systems also improves driver effectiveness across all levels of experience in all regions of the world.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xtant Medical Holdings (XTNT) Announces Resignation of CEO Dan Goldberger
- Interpace Diagnostics (IDXG) Enters Pact With Israeli Specialty Services Provider Best Med
- Minerva Neurosciences (NERV) Reports Additional Data Analyses From Phase IIb Trial of MIN-101 in Schizophrenia
Create E-mail Alert Related CategoriesCorporate News, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!